Therapeutic effects of thalidomide in myeloma are associated with the expression of fibroblast growth factor receptor 3

Thalidomide (Thal), a novel agent in the treatment of multiple myeloma, is presumed to act through a variety of mechanisms. In the present study, we examined the relationship between fibroblast growth factor receptor 3 (FGFR3) expression and the therapeutic effect of Thal. The DNA synthesis of KMS-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Shenxian, Somlo, George, Zhou, Bingsen, Yen, Yun
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661623/
https://www.ncbi.nlm.nih.gov/pubmed/18360564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661623/
https://www.ncbi.nlm.nih.gov/pubmed/18360564

Ejemplares similares